Distinct Probiotic Effects of Limosilactobacillus fermentum Perfectus001 and Bifidobacterium animalis subsp. lactis Perfectus006 in a Rat Model of Spleen qi Deficiency Syndrome

Spleen qi deficiency syndrome (SDS) is characterized by chronic fatigue, gastrointestinal dysfunction, and systemic metabolic disturbances and has been associated with gut microbial dysbiosis and chronic inflammation. This study evaluated the effects of two probiotic strains, Limosilactobacillus fermentum Perfectus001 (LFP) and Bifidobacterium animalis subsp. lactis Perfectus006 (BAP), in an SDS rat model. Both probiotic strains significantly ameliorated SDS-like phenotypes, including reduced blood lactate levels, improved endurance-related performance, and improved liver injury markers, as reflected by decreased serum ALT and AST levels. Gut microbiota profiling by 16 S rRNA gene sequencing revealed that LFP and BAP alleviated SDS-associated gut microbial dysbiosis by reducing Escherichia–Shigella , while increasing probiotic-responsive genera, such as Alistipes (adjusted p < 0.05). BAP also increased Parabacteroides relative to the model group. Colonic transcriptomic analysis showed that both strains attenuated inflammatory responses, with BAP more prominently reducing the expression of immune-related genes, including Il - 12b , Il - 17ra , and Il - 17rb . Hepatic transcriptomics further demonstrated distinct probiotic activities, with BAP preferentially suppressing inflammatory pathways, whereas LFP was associated with alterations in lipid and energy metabolism. Serum metabolomics showed that both strains partially corrected SDS-associated metabolic disturbances, including changes in biotin sulfone and several lipid- or bile acid-related metabolites. Integrated microbiota-metabolite correlation analysis further suggested that both probiotics influenced amino acid-related metabolism, particularly beta-alanine metabolism. Collectively, these findings demonstrate that LFP and BAP shared beneficial effects on SDS-associated phenotypes but differed in their modulation of gut microbiota and host responses, supporting their potential application as targeted probiotic interventions for improving gut health and immune homeostasis.

Authors

Institutions

Publication Details

Journal
Probiotics and Antimicrobial Proteins
Published
2026-11-19
DOI
https://doi.org/10.1007/s12602-026-11310-5
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Distinct Probiotic Effects of Limosilactobacillus fermentum Perfectus001 and Bifidobacterium animalis subsp. lactis Perfectus006 in a Rat Model of Spleen qi Deficiency Syndrome

Haoze Wu, Wenlong Colin Cai, Yanyan Zhao, Fuyong Li et al.
Probiotics and Antimicrobial Proteins
Probiotics and Fermented Foods
article

Distinct Probiotic Effects of Limosilactobacillus fermentum Perfectus001 and Bifidobacterium animalis subsp. lactis Perfectus006 in a Rat Model of Spleen qi Deficiency Syndrome

Haoze Wu, Wenlong Colin Cai, Yanyan Zhao, Fuyong Li, Yuan Yao Chen, Yanwu Chen, Xiaomin Li, Hualin Liu
article en

Abstract

Spleen qi deficiency syndrome (SDS) is characterized by chronic fatigue, gastrointestinal dysfunction, and systemic metabolic disturbances and has been associated with gut microbial dysbiosis and chronic inflammation. This study evaluated the effects of two probiotic strains, Limosilactobacillus fermentum Perfectus001 (LFP) and Bifidobacterium animalis subsp. lactis Perfectus006 (BAP), in an SDS rat model. Both probiotic strains significantly ameliorated SDS-like phenotypes, including reduced blood lactate levels, improved endurance-related performance, and improved liver injury markers, as reflected by decreased serum ALT and AST levels. Gut microbiota profiling by 16 S rRNA gene sequencing revealed that LFP and BAP alleviated SDS-associated gut microbial dysbiosis by reducing Escherichia–Shigella , while increasing probiotic-responsive genera, such as Alistipes (adjusted p < 0.05). BAP also increased Parabacteroides relative to the model group. Colonic transcriptomic analysis showed that both strains attenuated inflammatory responses, with BAP more prominently reducing the expression of immune-related genes, including Il - 12b , Il - 17ra , and Il - 17rb . Hepatic transcriptomics further demonstrated distinct probiotic activities, with BAP preferentially suppressing inflammatory pathways, whereas LFP was associated with alterations in lipid and energy metabolism. Serum metabolomics showed that both strains partially corrected SDS-associated metabolic disturbances, including changes in biotin sulfone and several lipid- or bile acid-related metabolites. Integrated microbiota-metabolite correlation analysis further suggested that both probiotics influenced amino acid-related metabolism, particularly beta-alanine metabolism. Collectively, these findings demonstrate that LFP and BAP shared beneficial effects on SDS-associated phenotypes but differed in their modulation of gut microbiota and host responses, supporting their potential application as targeted probiotic interventions for improving gut health and immune homeostasis.

Probiotics and Antimicrobial Proteins
City University of Hong Kong (HK), Zhejiang University (CN)
Probiotics and Fermented Foods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon